Ashwin S. Nathan, MD, MS

Interventional cardiologist and assistant professor of medicine at the Hospital of the University of Pennsylvania/Penn Medicine in Philadelphia, staff physician at the Corporal Michael J. Crescenz VA Medical Center 

Ashwin is a physician-scientist who seamlessly integrates clinical innovation, rigorous health services research, and executive leadership to transform how we deliver cardiovascular care. 

At 37, he has already published more than100 peer-reviewed manuscripts and, in just four years, secured nearly $1 million in independent funding. His groundbreaking research appears in JAMA Cardiology, JACC, Circulation and other premier journals. His investigations ask and answer critical questions about healthcare economics, technology adoption and health equity. 

Further, Dr. Nathan’s research provides vital insights for the business of cardiology. His landmark studies reveal, for example, how hospital financial margins influence clinical decision-making, how public quality ratings shape physician behavior and how geographic and socioeconomic factors create disparities in access to breakthrough technologies like TAVR. These findings inform healthcare executives, policymakers and administrators seeking evidence-based approaches to technology adoption and quality improvement. 

Clinically, Ashwin pioneers transcatheter electrosurgical procedures for structural heart disease, providing curative therapies for previously untreatable patients. His dual expertise in catheterization laboratory techniques and healthcare economics makes him a key opinion leader who bridges clinical medicine and business strategy. 

As his mentor Dr. Jay Giri has noted, Dr. Nathan “masters both the technical complexity of the cath lab and the economic realities of the modern healthcare system.” His commitment to health equity, innovative research methodologies and “lift as you climb” mentorship distinguish him as a transformative leader shaping the future of cardiovascular care delivery.